News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
389,926 Results
Type
Article (16509)
Company Profile (118)
Press Release (373293)
Multimedia
Podcasts (72)
Webinars (13)
Section
Business (114927)
Career Advice (528)
Deals (19091)
Drug Delivery (56)
Drug Development (32311)
Employer Resources (61)
FDA (9041)
Job Trends (7996)
News (176890)
Policy (12947)
Tag
2027 Bio NC Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (1427)
Accelerated approval (16)
Adcomms (1)
Allergies (94)
Alliances (35340)
ALS (57)
Alzheimer's disease (723)
Antibody-drug conjugate (ADC) (258)
Approvals (9330)
Artificial intelligence (569)
Autoimmune disease (135)
Automation (49)
Bankruptcy (136)
Best Places to Work (6735)
BIOSECURE Act (8)
Biosimilars (44)
Biotechnology (87)
Bladder cancer (70)
Brain cancer (38)
Breast cancer (325)
Cancer (2741)
Cardiovascular disease (187)
Career advice (475)
Career pathing (14)
CAR-T (245)
CDC (13)
Celiac Disease (1)
Cell therapy (622)
Cervical cancer (28)
Clinical research (27135)
Collaboration (1540)
Company closure (1)
Compensation (303)
Complete response letters (17)
COVID-19 (1290)
CRISPR (102)
C-suite (664)
Cystic fibrosis (62)
Data (3476)
Decentralized trials (2)
Denatured (29)
Depression (65)
Dermatology (36)
Diabetes (267)
Diagnostics (5428)
Digital health (47)
Diversity (9)
Diversity, equity & inclusion (11)
Drug discovery (222)
Drug pricing (26)
Drug shortages (6)
Duchenne muscular dystrophy (122)
Earnings (42141)
Editorial (14)
Employer branding (12)
Employer resources (55)
Events (55770)
Executive appointments (631)
FDA (11023)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (8)
Frontotemporal dementia (13)
Funding (1112)
Gene editing (212)
Generative AI (46)
Gene therapy (460)
GLP-1 (364)
Government (1459)
Grass and pollen (3)
Guidances (230)
Healthcare (10497)
HIV (33)
Huntington's disease (20)
IgA nephropathy (33)
Immunology and inflammation (90)
Immuno-oncology (37)
Indications (83)
Infectious disease (1484)
Inflammatory bowel disease (91)
Inflation Reduction Act (6)
Influenza (96)
Intellectual property (185)
Interviews (63)
IPO (8267)
IRA (12)
Job creations (1513)
Job search strategy (406)
JPM (22)
Kidney cancer (6)
Labor market (29)
Layoffs (151)
Leadership (10)
Legal (2663)
Liver cancer (52)
Longevity (19)
Lung cancer (300)
Lymphoma (212)
Machine learning (47)
Management (20)
Manufacturing (713)
MASH (47)
Medical device (12071)
Medtech (12190)
Mergers & acquisitions (11587)
Metabolic disorders (516)
mRNA (155)
Multiple sclerosis (73)
NASH (3)
Neurodegenerative disease (184)
Neuropsychiatric disorders (24)
Neuroscience (1332)
NextGen: Class of 2026 (3732)
Non-profit (1755)
Now hiring (20)
Obesity (180)
Opinion (127)
Ovarian cancer (123)
Pain (140)
Pancreatic cancer (136)
Parkinson's disease (167)
Partnered (20)
Patents (375)
Patient recruitment (345)
Peanut (37)
People (34995)
Pharmaceutical (18)
Pharmacy benefit managers (9)
Phase 1 (9982)
Phase 2 (12166)
Phase 3 (8020)
Pipeline (4575)
Policy (83)
Postmarket research (527)
Preclinical (4463)
Press Release (66)
Prostate cancer (136)
Psychedelics (11)
Radiopharmaceuticals (216)
Rare diseases (434)
Real estate (3477)
Recruiting (28)
Regulatory (11176)
Reports (20)
Research institute (1376)
Resumes & cover letters (85)
Rett syndrome (30)
RNA editing (13)
RSV (49)
Schizophrenia (40)
Series A (206)
Series B (138)
Service/supplier (6)
Sickle cell disease (58)
Special edition (4)
Spinal muscular atrophy (70)
Sponsored (25)
Startups (2611)
State (2)
Stomach cancer (3)
Supply chain (60)
Tariffs (14)
The Weekly (41)
Vaccines (581)
Venture capital (60)
Weight loss (76)
Women's health (71)
Worklife (5)
Date
Last 7 days (413)
Last 30 days (1717)
Last 365 days (15119)
2026 (6363)
2025 (15435)
2024 (19043)
2023 (22515)
2022 (31325)
2021 (33096)
2020 (31287)
2019 (26869)
2018 (20159)
2017 (19302)
2016 (18225)
2015 (21083)
2014 (15505)
2013 (12998)
2012 (14053)
2011 (14347)
2010 (13027)
Location
Africa (337)
Alabama (77)
Alaska (6)
Arizona (218)
Arkansas (12)
Asia (25468)
Australia (4445)
California (6465)
Canada (1945)
China (705)
Colorado (361)
Connecticut (290)
Delaware (131)
Europe (52753)
Florida (1105)
Georgia (258)
Hawaii (2)
Idaho (34)
Illinois (604)
India (50)
Indiana (306)
Iowa (9)
Japan (339)
Kansas (106)
Kentucky (25)
Louisiana (27)
Maine (23)
Maryland (849)
Massachusetts (4294)
Michigan (318)
Minnesota (471)
Mississippi (5)
Missouri (112)
Montana (29)
Nebraska (15)
Nevada (57)
New Hampshire (89)
New Jersey (1848)
New Mexico (19)
New York (1705)
North Carolina (898)
North Dakota (10)
Northern California (2879)
Ohio (207)
Oklahoma (19)
Oregon (25)
Pennsylvania (1240)
Puerto Rico (23)
Rhode Island (37)
South America (541)
South Carolina (79)
South Dakota (1)
Southern California (2786)
Tennessee (123)
Texas (1067)
United States (23760)
Utah (233)
Vermont (1)
Virginia (112)
Washington D.C. (20)
Washington State (576)
West Virginia (3)
Wisconsin (104)
Wyoming (1)
389,926 Results for "blue spark technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Amgen Makes up to $840M Cancer Play With Dark Blue Takeover
The acquisition is centered on Dark Blue Therapeutics’ small-molecule degrader of the MLLT1 and MLLT3 proteins, which is being tested for acute myeloid leukemia.
January 7, 2026
·
1 min read
·
Tristan Manalac
Press Releases
From SCAN to SPARK: Galaxy Brain Scientific Enables a New Paradigm in Non-invasive, Personalized Precision Treatment for Parkinson’s Disease
March 25, 2026
·
3 min read
Press Releases
NBDF’s Pathway to Cures Announces Spark Biomedical’s LUNA Trial to Advance Non-Pharmaceutical Options for Heavy Menstrual Bleeding
March 25, 2026
·
4 min read
Press Releases
Deep Blue Medical Closes Oversubscribed $5.6M Series A and Elevates Veteran Leader to COO
April 21, 2026
·
2 min read
Press Releases
Plus Therapeutics Secures Blue Shield of California Coverage for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
April 28, 2026
·
5 min read
IPO
2021 Sparked a Banner Year for Biotech IPOs. Where Are They Now?
Nearly 100 biotechs went public amid the industry’s IPO frenzy in 2021, driven by an influx of pandemic-driven investments. But many of those companies have little to show investors.
February 4, 2026
·
11 min read
·
Tristan Manalac
Layoffs
Spark Therapeutics Cuts 298 Employees as Part of Reorganization
Roche’s reorganization of Spark Therapeutics is coming more into focus, with nearly 300 employees being let go by the end of this year. Spark also trimmed its staff in 2024.
April 4, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Blue Genes Partners with RxSense to Deliver Actionable PGx at the Point of Adjudication
February 23, 2026
·
3 min read
Press Releases
Blue Circle Health Earns National Recognition from the American Diabetes Association
March 3, 2026
·
4 min read
Press Releases
SPARK NS Selects Nine Projects to Receive in Total Up to $18 Million in Funding to Advance Academic Discoveries in Autism and Parkinson’s Disease from the Lab to the Clinic
February 26, 2026
·
5 min read
1 of 38,993
Next
